Evaluating MRI correlates of lifestyle-based dementia risk reduction: Results from the AgeWell.de imaging study
BackgroundMultidomain lifestyle interventions can improve dementia risk by risk factor modification. Little is known about possible mechanisms underlying this effect.ObjectiveAnalyze whether changes in a validated dementia risk score were linked to changes in neuroimaging markers in a sample of older adults at increased dementia risk, participating in a multimodal lifestyle intervention.MethodsParticipants of the multi-centric AgeWell.de-trial at the Leipzig study site were examined using 3 Tesla MRI at baseline and 24-months follow-up, assessing markers of hippocampal-limbic atrophy and vascular pathology (hippocampal volume (HCV), entorhinal cortex thickness, free water fraction, peak width of skeletonized mean diffusivity, white matter hyperintensity volume, mean gray matter cerebral blood flow). Dementia risk was assessed using the Lifestyle for Brain Health (LIBRA)-index. Multivariable linear regression analyses assessed effects of changes in LIBRA on neuroimaging markers.ResultsOf 56 participants at baseline, 41 underwent the follow-up assessment (M<sub>age</sub>: 68.1 (4.1), % female: 46.3, intervention/control group: 16/25). Lower LIBRA-scores, indicating lower dementia risk, were associated with higher HCV at baseline. LIBRA improved in both groups, with no between-group difference in change. Increases in LIBRA were linked to smaller decline in HCV independently of the intervention. No further effects of lifestyle changes on neuroimaging were detected. Exploratory analyses indicated that detrimental lifestyle changes were linked to decreased cognitive performance in the intervention group.ConclusionsWe found no conclusive evidence for associations between lifestyle changes due to a multidomain lifestyle intervention and structural brain health markers. Larger samples and longer interventions may clarify underlying mechanisms.
Authors
- Toralf Mildner (ORCID: https://orcid.org/0000-0001-9163-1083)
- David Czock (ORCID: https://orcid.org/0000-0003-1217-5134)
- Andrea Zülke (ORCID: https://orcid.org/0000-0002-6026-8573)
- Thomas Frese (ORCID: https://orcid.org/0000-0001-9745-5690)
- Jochen René Thyrian (ORCID: https://orcid.org/0000-0001-6889-693X)
- Wiese Birgitt
- Melanie Luppa
- Frauke Beyer
- Arno Villringer
- Wolfgang Hoffmann
- A. Veronica Witte
- Jochen Gensichen
- Steffi G. Riedel-Heller
- Hans-Helmut König
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- Universität Hamburg (DE)
- University of Siegen (DE)
- Heidelberg University (DE)
- Universitätsmedizin Greifswald (DE)
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Heidelberg (DE)
- LMU Klinikum (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Medizinische Hochschule Hannover (DE)
- Bordeaux Population Health (FR)
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Leipzig (DE)
- Max Planck Institute for Human Cognitive and Brain Sciences (DE)
- Martin Luther University Halle-Wittenberg (DE)
- Ludwig-Maximilians-Universität München (DE)
- Leipzig University (DE)
Publication Details
- Journal
- Journal of Alzheimer s Disease
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1177/13872877251414423
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung